abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

25 Sep 2006

Author:
Red Herring [USA]

Indian Firms to Make HIV Drug - Gilead Sciences licenses AIDS treatment Tenofovir to eight more Indian companies

Eight more Indian companies have received nonexclusive licenses from Gilead Sciences to manufacture and distribute the HIV drug Tenofovir...The [eight] Indian drug companies that struck the licensing deal were [Ranbaxy Laboratories], Aurobindo Pharma, J.B. Chemicals and Pharmaceuticals, Alkem Laboratories, FDC, Matrix Laboratories, Medchem International, and Shasun Chemicals and Drugs. In August...Gilead Sciences announced similar agreements with three Indian drug companies: Hetero Drugs, Emcure Pharmaceuticals, and Strides Arcolab... Indian licensee companies are optimistic...that they can make the HIV drug accessible to people across the developing world. [also refers to Roche, Aspen Pharmacare, Cosmos Pharmaceuticals, Universal Corp. (Kenya)]